Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 2/20 | 0.57 |
| ▸ | ADRA1D | P25100 | 2/20 | 0.57 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.57 |
| ▸ | ADRA1B | P35368 | 2/20 | 0.57 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.45 |
| ▸ | NPC1 | O15118 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | HTT | P42858 | 1/20 | 0.42 |
| ▸ | CNR1 | P21554 | 1/20 | 0.42 |
| ▸ | CNR2 | P34972 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17018214 | 0.83 | MCHR1 (0.44) | MCHR1MEN1KMT2AKDM4ELMNA | |
| SCHEMBL18180893 | 0.80 | HTR1A (0.90) | HTR1AADRA1DADRA1AADRA1BALDH1A1 | |
| SCHEMBL6938193 | 0.79 | CNR1 (0.57) | MCHR1MEN1KMT2ATSHRLMNA | |
| SCHEMBL2917038 | 0.79 | CNR1 (0.57) | MCHR1MEN1KMT2ATSHRLMNA | |
| SCHEMBL347409 | 0.79 | CNR1 (0.57) | MCHR1MEN1KMT2ATSHRLMNA | |
| SCHEMBL1462495 | 0.79 | NCF1 (0.43) | MCHR1MEN1KMT2AHTTCNR1 | |
| SCHEMBL20434213 | 0.78 | HTR1A (0.87) | HTR1AADRA1DADRA1AADRA1BMEN1 | |
| SCHEMBL6976945 | 0.77 | HTR4 (0.57) | HTR1A | |
| SCHEMBL347955 | 0.77 | CNR1 (0.53) | MCHR1MEN1KMT2ALMNAHTT | |
| SCHEMBL12968475 | 0.76 | SMN1; SMN2 (0.52) | MCHR1SMN1; SMN2CNR1CNR2HTR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120016147-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2012-01-19 | — | — | US | disclosed |
| US-8048982-B2 | Method for producing aromatic compound polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-11-01 | — | — | US | disclosed |
| EP-2241548-A1 | Vanadium di-nuclear complex | Sumitomo Chemical Company, Limited (JP) | 2010-10-20 | — | — | EP | disclosed |
| EP-2241547-A1 | Method for producing aromatic compound polymer | Sumitomo Chemical Company, Limited (JP) | 2010-10-20 | — | — | EP | disclosed |
| US-20090018309-A1 | Method for Producing Aromatic Compound Polymer | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-01-15 | — | — | US | disclosed |
| EP-1767560-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | Sumitomo Chemical Company, Limited (JP) | 2007-03-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018309-A1 | Method for Producing Aromatic Compound Polymer | PAH, MAOA, AHR | HTR1A 1567/4885ADRA1D 1151/4885ADRA1A 131/4885 |
| US-20120016147-A1 | METHOD FOR PRODUCING AROMATIC COMPOUND POLYMER | PAH, MAOA, AHR | HTR1A 1577/4885ADRA1D 1192/4885ADRA1A 138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.